These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The emerging role of angiotensin-converting enzyme-2 in the kidney. Burns KD Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686 [TBL] [Abstract][Full Text] [Related]
30. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy. Tamura J; Konno A; Hashimoto Y; Kon Y Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318 [TBL] [Abstract][Full Text] [Related]
31. TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy. Casagrande V; Federici M; Menghini R Acta Diabetol; 2021 Dec; 58(12):1587-1594. PubMed ID: 34181080 [TBL] [Abstract][Full Text] [Related]
32. Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward. Blumenthal SS Postgrad Med; 2011 Nov; 123(6):166-79. PubMed ID: 22104465 [TBL] [Abstract][Full Text] [Related]
33. Genetic determinants of diabetic renal disease and their impact on therapeutic interventions. Schmidt S; Ritz E Kidney Int Suppl; 1997 Dec; 63():S27-31. PubMed ID: 9407416 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond. Nassirpour R; Raj D; Townsend R; Argyropoulos C Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770 [TBL] [Abstract][Full Text] [Related]
35. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051 [TBL] [Abstract][Full Text] [Related]
36. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810 [TBL] [Abstract][Full Text] [Related]
37. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring. Rossing K Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525 [No Abstract] [Full Text] [Related]
38. The role of circular RNA in Diabetic Nephropathy. Tu C; Wang L; Wei L; Jiang Z Int J Med Sci; 2022; 19(5):916-923. PubMed ID: 35693742 [TBL] [Abstract][Full Text] [Related]
39. Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-CoA carboxylase 2 silence in diabetic nephropathy. Xu Y; Huang J; Xin W; Chen L; Zhao X; Lv Z; Liu Y; Wan Q Metabolism; 2014 May; 63(5):716-26. PubMed ID: 24650564 [TBL] [Abstract][Full Text] [Related]